Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.

Michael Sergeevich Zastrozhin Aleksandr S Sorokin Tatyana V Agibalova Elena A Grishina Anastasiya P Antonenko Ilya N Rozochkin Denis O Lamoureux Valentin Yurievich Skryabin Tatyana E Galaktionova Ilya V Barna Anna V Orlova Albert D Aguzarov Ludmila M Savchenko Evgeny A Bryun Dmitry Alekseevich Sychev

Published in: Human psychopharmacology (2018)

Pharmacogenetic-guided personalization of drug dose in patients with alcohol withdrawal syndrome can reduce the risk of undesirable side effects and pharmacoresistance. It allows recommending the use of pharmacogenomic clinical decision support systems for optimizing drug dosage.

Keyphrases

clinical decision support
electronic health record
adverse drug
drug induced
emergency department